Trials

Our clinical trials span the continuum of dementia utilizing novel interventions and targets.

Trial Populations

AHEAD Study

PIs:

Reisa Sperling, Paul Aisen, Keith Johnson

A4 Open Label Extension (A4)

PIs:

Reisa Sperling, Paul Aisen

Alzheimer’s Plasma Extension Study (APEX)

PIs:

Reisa Sperling, Paul Aisen, Keith Johnson

Trial Ready Cohort for the Prevention of Alzheimer’s Dementia (TRC-PAD)

PIs:

Paul Aisen, Reisa Sperling, Jeffrey Cummings

Alzheimer’s Tau Platform (ATP) Clinical Trial

PIs:

Adam Boxer, Keith Johnson

Synaptic Therapy Alzheimer’s Research Trial (START)

PIs:

Christopher van Dyck, Anthony Caggiano

Life’s End Benefits of Cannabidiol and Tetrahyrdocannabinol (LiBBY)

PIs:

Jacobo Mintzer, Brigid Reynolds